J Pediatr. 1981 Apr;98(4):561-4. doi: 10.1016/s0022-3476(81)80760-3.
The accuracy of using the initial response to prednisone to identify children with minimal glomerular changes has been assessed in a prospective study of children between 12 weeks and 16 years of age with the primary nephrotic syndrome. The results indicate that, as generally held, the likelihood is quite high, although not 100%, that a child with the primary nephrotic syndrome who responds during eight weeks of initial intensive steroid treatment has MCNS. Prognosis in these patients can be considered to be very favorable and renal biopsy need not be done unless indicated by the subsequent clinical course. However, the prediction that a patient who fails to respond has a glomerular lesion other than MCNS would be incorrect in about one-fourth of all patients with the primary nephrotic syndrome, and in as many as one-half of patients less than or equal to 6 years of age. For these patients, predictions concerning prognosis should be withheld until a renal biopsy provides a histopathologic diagnosis.
在一项针对12周龄至16岁原发性肾病综合征患儿的前瞻性研究中,评估了利用对泼尼松的初始反应来识别微小病变型肾病患儿的准确性。结果表明,如普遍认为的那样,原发性肾病综合征患儿在最初8周强化类固醇治疗期间有反应,其患微小病变型肾病的可能性相当高,尽管不是100%。这些患者的预后可被认为非常良好,除非后续临床病程有指征,否则无需进行肾活检。然而,预测无反应的患者患有除微小病变型肾病以外的肾小球病变,在所有原发性肾病综合征患者中约四分之一是错误的,在6岁及以下患者中多达一半是错误的。对于这些患者,在肾活检提供组织病理学诊断之前,应暂不做预后预测。